| |
|
|
|
Urovant Sciences Ltd  
|
|
16.06 -0.01 (-0%) |
12-01 16:00 |
|
Open: |
16.1 |
Pre close: |
16.07 |
Target:
|
18.98
|
|
High: |
16.1 |
Low: |
16.04 |
Resistance:
|
16.25
18.98
|
|
Volume: |
156,664 |
Market Cap: |
509M |
Support:
|
10.63
7.15
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
16.08
 |
MACD |
MACD(12,26):
|
2.03 |
|
MA(20): |
12.88  |
Signal(12,26,9): |
1.83 |
|
MA(100): |
9.54 |
Stochastic Oscillator |
%K(14,3):
|
97.84 |
|
MA(250): |
10.44 |
%D(3): |
97.87 |
|
Average Volume(K) |
3-Month: |
30033
|
52-Week |
High:
|
16.25 |
|
10-Days: |
31195 |
Low: |
6.55 |
|
RSI |
RSI(14):
|
84.63 |
Change(%): |
38.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-4.430 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-4.485 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
